# Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes

> **NCT01028443** · PHASE4 · COMPLETED · sponsor: **Shahid Beheshti University of Medical Sciences**

## Conditions studied

- Endothelial Graft Rejection

## Interventions

- **DRUG:** Sandimmune
- **DRUG:** Artelose

## Key facts

- **NCT ID:** NCT01028443
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028443, "Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01028443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*